Jucaite, Aurelija <br/><br/>
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.  [electronic resource] 

 -  Psychopharmacology  Mar 2014 
 - 1251-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-2072 
<br/><br/><label>Standard No.: </label>10.1007/s00213-013-3116-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Attention Deficit Disorder with Hyperactivity--blood<br/>Bridged Bicyclo Compounds, Heterocyclic--adverse effects<br/>Cognition--drug effects<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Nicotinic Agonists--adverse effects<br/>Psychiatric Status Rating Scales<br/>Receptors, Nicotinic--metabolism<br/>Time Factors<br/>Tobacco Use Disorder--blood<br/>Treatment Outcome<br/>Young Adult